These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21252600)

  • 21. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
    Remková A; Kratochvíl'ová H; Durina J
    J Hum Hypertens; 2008 May; 22(5):338-45. PubMed ID: 18305548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercoagulability in heart failure.
    Jafri SM
    Semin Thromb Hemost; 1997; 23(6):543-5. PubMed ID: 9469627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of plasma coagulation and fibrinolysis in response to mental stress.
    Jern C; Eriksson E; Tengborn L; Risberg B; Wadenvik H; Jern S
    Thromb Haemost; 1989 Sep; 62(2):767-71. PubMed ID: 2814924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].
    Kohriyama T; Tanaka E; Katayama S; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.
    Bellart J; Gilabert R; Miralles RM; Monasterio J; Cabero L
    Gynecol Obstet Invest; 1998; 46(1):17-21. PubMed ID: 9692335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coagulologic characteristics of different stages of chronic circulatory insufficiency in atherosclerotic cardiosclerosis].
    Gritsiuk AI; Mamedov MB; Shchigel'skiĭ VI
    Kardiologiia; 1976 Dec; 16(12):25-32. PubMed ID: 1011478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure].
    Tereshchenko SN; Drozdov VN; Levchuk NN; Demidova IV
    Ter Arkh; 1998; 70(6):41-4. PubMed ID: 9695225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
    Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New concepts in coagulation.
    Rock G; Wells P
    Crit Rev Clin Lab Sci; 1997; 34(5):475-501. PubMed ID: 9405896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
    J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
    Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
    Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
    Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
    Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-control study indicates that coagulation imbalance is associated with arteriosclerosis and markers of endothelial dysfunction in kidney failure.
    Tran L; Pannier B; Lacolley P; Serrato T; Benetos A; London GM; Bézie Y; Regnault V
    Kidney Int; 2021 May; 99(5):1162-1172. PubMed ID: 33359501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
    Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
    Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
    Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
    Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.